Manifestaciones gastrointestinales asociadas al COVID-19

Gastrointestinal manifestations associated with COVID-19

Palabras clave: SARS-COV-2, COVID-19, Vacunas

Resumen

La infección por SARS-CoV-2 es responsable del COVID-19 que ha afectado a millones de personas y muertes en el mundo, se necesita con urgencia vacunas a toda la población. En tal sentido, la tecnología moderna ha permitido el desarrollado de vacunas eficaces en distintas partes del mundo como Estados Unidos, Alemania, Reino Unido, Rusia, China entre otros; para controlar la pandemia por COVID-19. En esta revisión se detallaran las características de las vacunas que alcanzaron estudios de fase III y que actualmente se están aplicando en los esquemas de vacunación en la población mundial contra el COVID-19. Existen dudas si estas vacunas creadas en tiempo record producen inmunidad permanente o si protege contra mutaciones del SARS-CoV-2 y los efectos adversos a largo plazo.

Citas

Cha M, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. World J Gastroenterol 2020;26(19):2323-2332.

Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, y cols. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am J Gastroenterol 2020;115(5):766-773.

Mao R, Qiu Y, He J, Tan J, Li X, Liang J, Shen J, y cols. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-678.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, y cols; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382(18):1708-1720.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, y cols. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, y cols; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-1581.

Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, y cols. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis 2020;71(15):889-890.

Mao R, Qiu Y, He J, Tan J, Li X, Liang J, y cols. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-678.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, y cols. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323(11):1061-1069.

Jin X, Lian J, Hu J, Gao J, Zheng L, Zhang Y, y cols. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020;69(6):1002-1009.

Wang F, Wang H, Fan J, Zhang Y, Wang H, Zhao Q. Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia. Gastroenterology 2020;159(1):367-370.

Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, Raizada MK, Grant MB, Oudit GY. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res 2020;126(10):1456-1474.

Wang K, Gheblawi M, Oudit GY. Angiotensin Converting Enzyme 2: A Double-Edged Sword. Circulation. 2020 Aug 4;142(5):426-428.

Gentile S, Strollo F, Mambro A, Ceriello A. COVID-19, ketoacidosis and new-onset diabetes: Are there possible cause and effect relationships among them? Diabetes Obes Metab. 2020 Dec;22(12):2507-2508.

Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology 2020;158(6):1518-1519.

Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, y cols. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477-81.

Jin X, Lian J, Hu J, Gao J, Zheng L, Zhang Y, y cols. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020;69(6):1002-1009.

Song Y, Liu P, Shi XL, Chu YL, Zhang J, Xia J, Gao XZ, Qu T, Wang MY. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020 Jun;69(6):1143-1144.

Launois S, Bizec JL, Whitelaw WA, Cabane J, Derenne JP. Hiccup in adults: an overview. Eur Respir J 1993;6(4):563-75.

Woelk C. Managing hiccups. Can Fam Physician 2011;57(6):672-5, e198-201.

Ferrarese C, Silani V, Priori A, Galimberti S, Agostoni E, Monaco S, Padovani A, Tedeschi G; Italian Society of Neurology (SIN). An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID). Neurol Sci. 2020 Jun;41(6):1355-1359.

Prince G, Sergel M. Persistent hiccups as an atypical presenting complaint of COVID-19. Am J Emerg Med. 2020 Jul;38(7):1546.e5-1546.e6.

Lechien J, Chiesa C, De Siati D, Horoi M, Le Bon S, Rodriguez A, y cols. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261.
Publicado
2021-04-30
Cómo citar
Mengual-Moreno, E., & Lizarzábal-García, M. (2021). Manifestaciones gastrointestinales asociadas al COVID-19: Gastrointestinal manifestations associated with COVID-19. Revista Profesional HígadoSano, (20), 8-12. Recuperado a partir de https://produccioncientificaluz.org/index.php/higadosano/article/view/35784
Sección
Artículos